COVID-19 re-shaped the life sciences industry. In the race to find a vaccine, widespread collaboration became the norm, with pharmaceutical companies, not-for-profits and academic institutions sharing data and research. Trust in big pharma increased, with 49 percent of people saying they view the pharmaceutical industry more positively than before the pandemic.1
